What is Castle Biosciences's stock issuance proceeds?

Castle Biosciences (CSTL) reported stock issuance proceeds of $322K in Q1 2026.

How has Castle Biosciences's stock issuance proceeds changed year-over-year?

Castle Biosciences's stock issuance proceeds increased by 1688.9% year-over-year, from $18K to $322K.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Castle Biosciences CSTL Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

VeracyteVCYT

$2.74M-7.8%

Personalis, Inc.PSNL

$20.95M+17.8%

NeoGenomicsNEO

-$338K-136%

Fulgent Genetics, Inc.FLGT

$9K—

Cogent Biosciences, Inc.COGT

$5.76M+4,132%

GeneDx HoldingsWGS

$476K—

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's stock issuance proceeds?: Castle Biosciences (CSTL) reported stock issuance proceeds of $322K in Q1 2026.
How has Castle Biosciences's stock issuance proceeds changed year-over-year?: Castle Biosciences's stock issuance proceeds increased by 1688.9% year-over-year, from $18K to $322K.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.